About Contact Us Careers

Wearable Injectors Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3300
Published Date: Aug 29, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Wearable Injectors Landscape

Amgen Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Insulet Corporation
YPSOMED AG
Becton, Dickinson and Company
Tandem Diabetes Care, Inc.
Enable Injections, Inc.
West Pharmaceutical Services, Inc.
Medtronic plc
Q Core Medical Ltd.
United Therapeutic Corporation

Browse Key Market Insights with Data Illustration:

Wearable Injectors Market Size & Share, Growth Trends 2036

In the News

April 2021: Amgen Inc. announced the successful acquisition of Five Prime Therapeutics, which is aimed to enhance Amgen's proficiencies in treating metastatic gastric and gastroesophageal junction cancers in the markets with high prevalence of the diseases such as Japan, South Korea, and Latin America.

Author Credits: Radhika Pawar

Report ID: 3300
Published Date: Aug 29, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of wearable injectors is evaluated at USD 9.36 billion.

Wearable Injectors Market size was valued at USD 8.63 billion in 2023 and is set to cross USD 31.98 billion by 2036, expanding at more than 10.6% CAGR during the forecast period i.e., between 2024-2036. The rising prevalence of chronic medical conditions and the technological developments in drug delivery injectors globally will fuel the market growth.

Asia Pacific is likely to dominate majority revenue share by 2036, owing to large elderly population in many countries of the region such as China and Japan, and the increasing prevalence of chronic disorders in the region.

The major players in the market include Amgen Inc., Insulet Corporation, YPSOMED AG, among others.

Inquiry Before Buying Request Free Sample